Table 2.
Gender | Age Category | Injury Mechanism | Previous ACL Reconstruction | Contralateral ACL Injury | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Male | Female | <21 y | 21-35 y | Noncontact | Contact | No | Yes | No | Yes | |
P | n.s. | n.s. | n.s. | n.s. | n.s | |||||
Cramer V | 0.15 | 0.13 | 0.15 | 0.01 | 0.16 | |||||
Total (n) | 282 | 89 | 134 | 237 | 240 | 131 | 331 | 40 | 320 | 51 |
S1 | 77 27% [22-33] |
27 30%[21-40] |
45 34% [26-42] |
59 25% [19-30] |
62 26% [20-31] |
42 32% [24-40] |
93 28% [23-33] |
11 27.5% [14-41] |
93 29% [24-34] |
11 21.5% [10-33] |
S2 | 31 11% [7-14] |
18 20% [12-29] |
17 13% [7-18] |
31 13% [9-17] |
37 16% [11-20] |
11 8% [4-13] |
41 12% [9-16] |
7 17.5% [6-29] |
35 11% [8-14] |
13 25% [14-37] |
S3 | 46 16% [12-21] |
14 16% [8-23] |
24 18% [11-24] |
36 15% [11-20] |
34 14% [10-19] |
26 20%[13-27] |
51 15.5% [12-19] |
9 22.5% [10-35] |
51 16% [12-20] |
9 17.5% [7-28] |
S4 | 46 16% [12-21] |
13 15% [7-22] |
19 14% [8-20] |
40 17% [12-22] |
36 15% [10-20] |
23 18% [11-24] |
53 16% [12-20] |
6 15% [4-26] |
53 17% [12-21] |
6 12% [3-21] |
S5 | 38 13% [9-17] |
7 8% [2-13] |
15 11% [6-17] |
30 13% [8-17] |
32 13% [9-18] |
13 10% [5-15] |
42 13% [9-16] |
3 7.5% [–1-16] |
39 12% [9-16] |
6 12% [3-21] |
S6 | 45 16% [12-20] |
10 11% [5-18] |
14 10% [5-16] |
41 17% [12-22] |
39 16% [7-18] |
16 12% [7-18] |
51 15.5% [12-19] |
4 10% [1-19] |
49 15% [11-19] |
6 12% [3-21] |
n, % [95% CI]. n.s., not significant.